This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Bence Jones protein

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Bence Jones protein (BJP) is the name given to monoclonal light chains which are filtered by the kidney. There presence in the urine indicates a paraproteinaemia, often multiple myeloma.

Classically BJP is detected by heating urine to 45-55 deg.C. whereupon the protein coagulates. The precipitant redissolves on boiling.

BJP is most accurately detected by urine protein electrophoresis. Immunofixation allows the monoclonal nature of the constituent light chains to be confirmed.

Note that NICE guidance now recommends the use of serum free light chains (SFLC) rather than urinary Bence Jones protein (BJP) in the assessment of possible multiple myeloma, and studies have validated this:

SFLC replaces BJP in these guidelines (1)

  • although it is noted that BJP may still be required for some clinical trials


Urine albumin:creatinine ratio along with troponin and Nterminal pro-B-type natriuretic peptide (NT-proBNP) can be a useful screening tool for detecting amyloid.

Reference:

  • Sive, J., Cuthill, K., Hunter, H., Kazmi, M., Pratt, G., Smith, D. and (2021), Guidelines on the diagnosis, investigation and initial treatment of myeloma: a British Society for Haematology/UK Myeloma Forum Guideline. Br. J. Haematol., 193: 245-268. https://doi.org/10.1111/bjh.17410

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.